Generali Investments Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Hold
4,837
0.53% 45
2026
Q1
$2.38M Sell
4,837
-876
-15% -$475K 0.55% 36
2025
Q4
$3.31M Sell
5,713
-1,325
-19% -$749K 0.66% 38
2025
Q3
$3.41M Buy
7,038
+1,104
+19% +$514K 0.71% 26
2025
Q2
$2.4M Buy
5,934
+675
+13% +$282K 0.54% 50
2025
Q1
$2.62M Buy
5,259
+384
+8% +$208K 0.74% 37
2024
Q4
$2.54M Buy
+4,875
New +$2.68M 0.66% 38

Other funds holding TMO

Generali Investments Management's TMO Position: Q2 2026 in Review

Generali Investments Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 4,837 shares worth $2.43M. The position accounts for 0.53% of the portfolio, ranked #45.

Generali Investments Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.41M in Q3 2025. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Generali Investments Management held 4,837 shares of Thermo Fisher Scientific worth $2.43M as of Q2 2026.
  • Generali Investments Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.53% of Generali Investments Management's portfolio in Q2 2026, its #45 holding.
  • Generali Investments Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments Management's Thermo Fisher Scientific position peaked at $3.41M in Q3 2025.
  • 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.